Discontinuation report KIDROLASE
Report ID | 108355 |
Drug Identification Number | 01926438 |
Brand name | KIDROLASE |
Common or Proper name | L-asparaginase powder for solution |
Company Name | JAZZ PHARMACEUTICALS FRANCE SAS |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ASPARAGINASE |
Strength(s) | 10000UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 1 vial/pack |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | 2020-11-10 |
Actual discontinuation date | 2021-06-30 |
Remaining supply date | 2020-02-29 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 84 QUAI CHARLES DE GAULLE CITY ONE LYON, AUVERGNE-RHONE-ALPES FRANCE 69006 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-09-01 | French | Compare |
v5 | 2021-09-01 | English | Compare |
v4 | 2021-09-01 | English | Compare |
v3 | 2020-03-10 | French | Compare |
v2 | 2020-03-10 | English | Compare |
v1 | 2020-03-10 | English | Compare |
Showing 1 to 6 of 6